Trial Profile
Effect of Treatment Using rhIL-11 in Patients With Thrombocytopenia After Chemotherapy for Childhood Acute Lymphoblastic Leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2014
Price :
$35
*
At a glance
- Drugs Oprelvekin (Primary)
- Indications Pancytopenia
- Focus Therapeutic Use
- 17 Dec 2014 New trial record